Skip to main content
SpringerLink
Log in
Book cover

Tumor Prevention and Genetics pp 140–148Cite as

Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 163))

Abstract

Early detection of breast cancer has been studied for effectiveness in reducing mortality for more than four decades. During this period numerous studies took place, with more than half a million participating women. In spite of large amounts of nonconflicting data, different countries took varying lengths of time to establish a policy, and came up with a variety of policies, quite different from one another. Inherent differences between the countries in structure of the health system, in the commitment to public health activities, and in opinions and health habits of the relevant populations may explain these different outcomes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shapiro S, Venet W, Strax, Venet L (1988) Periodic screening for breast cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986. Baltimore, The Johns Hopkins University Press

    Google Scholar 

  2. Baker LH (1982) Breast Cancer Detection Demonstration Project: five year summary report. Ca Cancer J Clin 32:194–225s

    Article  PubMed  CAS  Google Scholar 

  3. Andersson L, Aspegren K, Janzon L, et al (1988) Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 297:943–948

    Article  PubMed  CAS  Google Scholar 

  4. Roberts MM, Alexander FE, Anderson TJ, et al (1990) Edinburgh trial of screening for breast cancer. Mortality at seven years. Lancet 335:241–246

    Article  PubMed  CAS  Google Scholar 

  5. Tabar L, Fagerberg G, Duffy SW, et al (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187–210

    PubMed  CAS  Google Scholar 

  6. Miller AB, Baines C, To T, Wall C (1992) Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 147:1477–1488

    PubMed  CAS  Google Scholar 

  7. Frisell J, Eklund G, Hellstrom, et al (1991) Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18:49–56

    Article  PubMed  CAS  Google Scholar 

  8. Nystrom L, Rutqvist LE, Wall S, et al (1993) Breast cancer screening with mammography: an overview of the Swedish randomized trials. Lancet 341:973–978

    Article  PubMed  CAS  Google Scholar 

  9. de-Waard F, Collette HJ, Rombach JJ, Baanders van Halewijn EA, Honing C (1984) The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 37:1–44

    Article  PubMed  CAS  Google Scholar 

  10. Verbeek AL, Hendriks JH, Holland R, Mravunac M, Sturmans F, Day NE (1984) Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975–1981. Lancet 1:1222–1224

    Article  PubMed  CAS  Google Scholar 

  11. United Kingdom trial of Early Detection of breast cancer group (1988) 16-year mortality from breast cancer in the United Kingdom Trial of early detection of breast cancer. Lancet 2:411–416

    Google Scholar 

  12. Palli D, Del Turco MR, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni G (1961) A casecontrol study of the efficacy of a nonrandomized breast cancer screening program in Florence (Italy). Int J Cancer 38:501–504

    Article  Google Scholar 

  13. Miller AB, To T, Baines C, Wall C 2000 Canadian National Breast Screening Study-2: 13 Year results of a randomized trial in women aged 50–59 Years. JNCI 92:1490–1499

    Article  PubMed  CAS  Google Scholar 

  14. Ringash J (2001) Canadian Task Force on Preventive Health Care. Screening mammography among women aged 40–49 years at average risk of breast cancer. CMAJ 164:469–476

    PubMed  CAS  Google Scholar 

  15. Guide to Clinical Preventive Services (1996) Report of the US Preventive Services Task Force, 2nd edn. Williams & Wilkins, Baltimore, pp 73–88.

    Google Scholar 

  16. Recommendations of the Committee of Cancer Experts on Breast Cancer Screening (1992) 6 April. European Commission

    Google Scholar 

  17. Shapiro S, Coleman EA, Broeders M, Codd M, de-Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R (1998) Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 27:735–42

    Article  PubMed  CAS  Google Scholar 

  18. National Institutes of Health. National Cancer Institute (1997) Consensus development conference on screening mammography in women under age 50. L. Gordis, Chairman

    Google Scholar 

  19. NCI-PDQ (1997) Cancer Facts. Research studies on screening mammography

    Google Scholar 

  20. Thomas DB, Gao DL, Self SG, Allison CJ, Tao Y, Mahloch J, et al (1997) Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. JNCI 9:355–365

    Article  Google Scholar 

  21. Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA (1993) Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer 29A:2039–2046

    PubMed  CAS  Google Scholar 

  22. Holmberg L, Ekbom A, Calle E, Mokdad A, Byers T (1997) Breast cancer mortality in relation to self-reported use of breast self examination. A cohort study of 450,000 women. Breast Cancer Res Treat 43:137–140

    Article  PubMed  CAS  Google Scholar 

  23. Baxter N, CTFPHC (2001) Should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 164:1837–1846

    PubMed  CAS  Google Scholar 

  24. Gotzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355:129–134

    Article  PubMed  CAS  Google Scholar 

  25. Olsen O, Gotzsche PC (2001) Cochrane review on screening for breast cancer with mammography. Lancet 358:1340–1342

    Article  PubMed  CAS  Google Scholar 

  26. EBCG editors, Cochrane Collaboration (2002) Screening mammography: setting the record straight. Lancet 359:439–440

    Google Scholar 

  27. Olsen O, Gotzsche PC (2001) Screening for breast cancer with mammography (Cochrane Review). In: The Cochrane Library. Issue 4. Oxford: Update software

    Google Scholar 

  28. Horton R (2001) Screening mammography-an overview revisited. Lancet 358:1284–1285

    Article  PubMed  CAS  Google Scholar 

  29. P.D.Q. Screening and Prevention Editorial Board. January 24, 2002 Expert Panel Cites Doubts on Mammogramls Worth By GINA KOLATA, New York Times, 2002, US

    Google Scholar 

  30. Miettinen OS, Henschke C, Pasmantier MW, Smith JP, Libby DM Yankelevitz DF (2002) Mammographic screening: no reliable supporting evidence? Lancet 359:404–406

    Article  PubMed  Google Scholar 

  31. Roubidoux MA, Wilson TE, Orange RJ, Fitzgerald JT, Helvie MA, Packer S-A (1998) Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method. Radiology 208:725–8

    PubMed  CAS  Google Scholar 

  32. Banks E (2001) Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen 8:29–34

    Article  PubMed  CAS  Google Scholar 

  33. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171–176

    Article  PubMed  CAS  Google Scholar 

  34. Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355:270–274

    Article  PubMed  CAS  Google Scholar 

  35. Seradour B, Esteve J, Heid P, Jacquemier J (1999) Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme. J Med Screen 6:99–102

    PubMed  CAS  Google Scholar 

  36. Stoutjesdijk MJ, Boetes C, Jager GJ, Beex I, Bult P, Herndriks JH, Laheij R, Massuger L, van Die LE, Wobbes T, Barentsz JO (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. JNCI 18:1095–102

    Article  Google Scholar 

  37. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M (2000) First experience in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53–60

    Article  PubMed  CAS  Google Scholar 

  38. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PI, Cole DE, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Narod SA (2001) Comparison of breast magnetic resonance imaging, mammography and ultra sound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–31

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Community Medicine and Epidemiology, Carmel Medical Center and Technion Faculty of Medicine, 7 Michal St., Haifa, 34362, Israel

    Gad Rennert

  2. Clalit Health Services (CHS) National Cancer Control Center, National Israeli Breast Cancer Detection Program, 7 Michal St., Haifa, 34362, Israel

    Gad Rennert

Authors
  1. Gad Rennert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Tumordiagnostik und Prävention, Rorschacherstr. 150, 9006, St. Gallen, Switzerland

    Hans-Jörg Senn  & Rudolf Morant  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rennert, G. (2003). Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World. In: Senn, HJ., Morant, R. (eds) Tumor Prevention and Genetics. Recent Results in Cancer Research, vol 163. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55647-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55647-0_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62892-4

  • Online ISBN: 978-3-642-55647-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation